Goldenwell Biotech (GWLL) Total Liabilities (2020 - 2025)
Goldenwell Biotech (GWLL) has disclosed Total Liabilities for 6 consecutive years, with $315233.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Total Liabilities rose 58.67% year-over-year to $315233.0, compared with a TTM value of $315233.0 through Sep 2025, up 58.67%, and an annual FY2024 reading of $271433.0, up 88.71% over the prior year.
- Total Liabilities was $315233.0 for Q3 2025 at Goldenwell Biotech, down from $338133.0 in the prior quarter.
- Across five years, Total Liabilities topped out at $338133.0 in Q2 2025 and bottomed at $29126.0 in Q3 2022.
- Average Total Liabilities over 5 years is $144873.7, with a median of $145222.0 recorded in 2024.
- The sharpest move saw Total Liabilities plummeted 81.16% in 2022, then soared 282.36% in 2024.
- Year by year, Total Liabilities stood at $159266.0 in 2021, then tumbled by 70.63% to $46782.0 in 2022, then skyrocketed by 207.46% to $143837.0 in 2023, then surged by 88.71% to $271433.0 in 2024, then rose by 16.14% to $315233.0 in 2025.
- Business Quant data shows Total Liabilities for GWLL at $315233.0 in Q3 2025, $338133.0 in Q2 2025, and $273533.0 in Q1 2025.